Dr. Huybert Groenendaal is a Managing Partner at EpiX Analytics, which specializes in risk analysis and modeling techniques for clients around the world. Dr. Groenendaal consults on a broad range of projects that include forecasting, financial risk analysis, project costs estimation, pharmaco-economics, epidemiology, inventory optimization, mining and transportation. He has extensive experience in risk modeling and analysis for business development, financial valuation, R&D portfolios and portfolio evaluations in pharmaceuticals and medical devices. Dr. Groenendaal organizes and teaches “Quantitative Risk Analysis”, “Project Risk Analysis”, and “Corporate Risk Analysis” courses worldwide and lectures on risk analysis in the executive MBA program at the Leeds School of Business, University of Colorado at Denver and at the school of Management at the University of Texas at Dallas.